Pharmaceuticals, Biotechnology and Life Sciences
Company announcement no. 29 – 21 7 December 2021 Reporting of transactions made by persons discharging managerial responsibilities and persons closely…
A Phase 2 trial of intra-articular RTX for knee OA pain has enrolled its first two patients.The injections were well…
Oslo (Norway), 7 December 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the company…
Combined testing from two contracts averages 1,000 PCR samples per dayTesting potential for the two contracts could ramp up to…
Collaboration aims to identify variants not easily detectible by short-read sequencing, increasing diagnostic yield in rare disease patientsMENLO PARK, Calif.,…
Sorrento has received accreditation from the American College of Pathologists, which allows Sorrento to bill to Medicare and MedicaidSAN DIEGO,…
Bavarian Nordic A/S (“Bavarian Nordic” or the “Company”) announced its intention to raise new capital through an accelerated bookbuilding process.…
BOSTON, Dec. 06, 2021 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be attending and…
-Workforce reduction of 65% -Prioritization of lead program TTP399, a potentially transformative treatment for the reduction of hypoglycemic episodes in…
PHILADELPHIA, Dec. 06, 2021 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (Nasdaq: CNTX) (“Context Therapeutics” or the “Company”), a women’s oncology…